Obstructive Airway Disease: Difficulty Expelling Air
This presentation describes classic obstructive airway disease, most commonly COPD or asthma, where expiratory flow limitation causes air trapping and hyperinflation—making exhalation difficult while inspiration remains relatively preserved.
Underlying Mechanism
The core problem is expiratory flow limitation, which is the pathophysiologic hallmark of obstructive lung disease 1. This creates:
- Dynamic hyperinflation: Air becomes trapped because exhalation is incomplete before the next breath begins, progressively increasing lung volumes above resting values 1
- Increased work of breathing: The respiratory muscles must work against both increased airway resistance and the mechanical disadvantage of hyperinflation 2
- Intrinsic PEEP (PEEPi): Positive pressure remains in the airways at end-expiration, requiring extra effort to initiate the next breath 2
The sensation of dyspnea arises from neuromechanical dissociation—an imbalance between the increased inspiratory neural drive to breathe and the impaired mechanical response of the respiratory system 3, 1.
Immediate Assessment
Determine severity to guide management location 4:
- Mild exacerbation: Manage at home with close follow-up within 48 hours 4
- Moderate-to-severe: Evaluate in Emergency Department 4
- Life-threatening: Direct ICU admission 4
Key severity indicators include 4:
- Ability to speak in full sentences
- Respiratory rate and use of accessory muscles
- Oxygen saturation
- Level of consciousness
- Hemodynamic stability
Management Strategy
Pharmacologic Interventions
Bronchodilators are first-line therapy because they improve dynamic airway function, enhance lung emptying, and reduce hyperinflation 1:
- Initiate, increase dose/frequency, or combine β2-agonists and anticholinergics 4
- Long-acting bronchodilators reduce hyperinflation during both rest and exercise, allowing greater tidal volume expansion for a given inspiratory effort 1
- Consider short-course corticosteroids (0.4–0.6 mg/kg daily) if marked wheeze is present 4
Antibiotics if bacterial infection is suspected as the usual cause of exacerbations is infection 4.
Non-Pharmacologic Interventions
These are essential complements that target different mechanisms 3, 2:
- Pulmonary rehabilitation (chest therapy, patient education, exercise training) is established as effective for quality of life and dyspnea 2
- Encourage sputum clearance by coughing and consider home physiotherapy 4
- Encourage fluid intake to facilitate secretion clearance 4
- Controlled oxygen therapy targeting SpO2 88-92% to avoid hypercapnia 5
Advanced Interventions for Severe Cases
Noninvasive positive pressure ventilation (NIV) may be effective for severe dyspnea 2:
- CPAP counteracts the deleterious effect of PEEPi in patients with severe hyperinflation 2
- NIV has been shown effective on dyspnea sensation and quality of life in COPD with severe hypercapnia 2
- In obesity hypoventilation syndrome, high PEEP settings (10-15 cm H2O) may be needed to recruit collapsed lung units 5
Critical Pitfalls to Avoid
- Never use sedatives or hypnotics during acute exacerbations as they suppress respiratory drive 4
- Avoid excessive oxygen in COPD patients—use controlled oxygen therapy to prevent worsening hypercapnia 5
- Do not delay hospital assessment if severity is uncertain—err on the side of caution 4
- Recognize that deconditioning creates a "dyspnea spiral": Patients avoid activity due to breathlessness, leading to muscle deconditioning, social isolation, and worsening symptoms 3
Follow-Up Instructions
Instruct patients on symptoms and signs of worsening 4:
- Increased breathlessness at rest
- Inability to complete sentences
- Confusion or drowsiness
- Cyanosis
Action to take: Contact primary care physician immediately or go to Emergency Department 4.
Reassess within 48 hours for home-managed exacerbations to determine if step-down or escalation of therapy is needed 4.